Eperisone compared to physiotherapy on muscular tone of stroke patients: A prospective randomized open study

Journal of the Pakistan Medical Association

Volumn 55, Issue 5, 2005, Pages 202-204

  Tariq, Mohammad ^a   Akhtar, Nasim ^a   Ali, Mohammad ^a   Rao, Sohail ^a   Badshah, Mazhar ^a   Irshad, Mohammad ^a  

^a PAKISTAN INSTITUTE OF MEDICAL SCIENCES   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

EPERISONE; CENTRAL MUSCLE RELAXANT; MUSCLE RELAXANT AGENT; PROPIOPHENONE DERIVATIVE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG SAFETY; DRUG TOLERABILITY; EPIGASTRIC PAIN; FATIGUE; FEMALE; HEADACHE; HUMAN; MALE; MUSCLE TONE; OPEN STUDY; PHYSIOTHERAPY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SPASTICITY; STROKE; SYSTOLIC BLOOD PRESSURE; VOMITING; XEROSTOMIA; ADOLESCENT; CEREBROVASCULAR ACCIDENT; COMPARATIVE STUDY; MIDDLE AGED; PARALYSIS;

ADOLESCENT; ADULT; AGED; CEREBROVASCULAR ACCIDENT; HUMANS; MIDDLE AGED; MUSCLE RELAXANTS, CENTRAL; MUSCLE SPASTICITY; NEUROMUSCULAR AGENTS; PARALYSIS; PHYSICAL THERAPY MODALITIES; PROPIOPHENONES; PROSPECTIVE STUDIES;

EID: 22344434047     PISSN: 00309982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Satoyoshi, E. Therapeutic effects of dantrolene sodium on cerebral and Spinal spastic paralysis. Strides of Med 1978;104:294.
2. Satoyoshi, E. Double blind studies with Baclofen in cerebral and Spinal spastic paralysis. Diag and Treat 1977;65,1328.
3. Merritt JL. Management of spasticity in spinal cord injury. Mayo Clin Proc 1981;56:614-22.
4. Gelber DA, Jozefczyk PB. Therapeutics in the management of spasticity. Neurorehabil Neural Rep 1999;13:5-14.
5. Pinder RM, Brogden RN, Speight TM, Avery GS. Dantrolene sodium: a review of its pharmacological properties and therapeutic efficacy in spasticity. Drugs 1997;13:3-23.
6. Davidoff RA. Antispasticity drugs: mechanisms of action. Ann Neural 1985;17:107-16.
7. Young RR, Delwaide PJ. Drug therapy: spasticity. N Engl J Med 1981;304:28-33.
8. Drug facts and comparisons. St Louis: Wolters Kluvier, 1999.
9. Treating post-stroke spasticity. Cindy Ivanhoe, MD; Baylor College of Medicine, TX. Webcastsl with Ivanhoe CB, Daily News Health, Published/last reviewed: 7/11/2002 (nydailynews.healthology.com).
10. Nance PW. Tizanidine: an alpha2 agonist imidazoline with antispasticity effects. Today's Therapeutic Trends 1997;15:11-25.
11. Ohtomo E. Clinical effects of E-0646 on contracture and spasmodic paralysis. Control study with placebo. Medical consultation and new remedies 1982;19:2073-96.
12. Yoshigoro. Clinical studies with E-0646 (Eperisone Hydrochloride). In: Spastic paralysis. Jap J Clin Experiment Med 1980;57:4033-38.
13. Nishikata K, Shimomura T, Takahashi K. Clinical examination of eperisone hydrochloride (Myonal) on headache caused by muscle tension. Med Consult N Remedy 1985;22:1-20.